|
National Headache
Foundation
Clinical Update: Caffeine and Headache
Preface
The National Headache Foundation
(NHF), a non-profit organization dedicated to serve as
an information resource to headache sufferers, their
families and the healthcare providers who treat them,
convened a distinguished, multidisciplinary
faculty to review and clarify issues regarding the
relationship between caffeine and headache. Our expert panel addressed topics of importance to clinicians
involved in diagnosing or treating patients with headache
disorders. Specifically, the purpose of the meeting
was to:
- Review the professional literature about caffeine
and its relationship with headache
- Provide detailed analyses of important subtopics,
such as safety, efficacy, dosing,
rebound, withdrawal, and addiction
- Summarize findings for medical professionals
- Translate relevant
information into patient-education materials
This publication, aimed at medical professionals, is
intended to provide a scientific summary of published
research involving caffeine.
Faculty affiliations
Faculty affiliations and presentation topics included:
- Jerome Goldstein, MD, Director, San Francisco Headache
Clinic, San Francisco, CA
"Caffeine in headache therapy."
- Merle Diamond, MD, Associate Director, Diamond Headache
Clinic, Chicago, IL
"Caffeine as an analgesic adjuvant."
- Robert E. Ryan, Jr., MD, Executive Director, Ryan Headache
Center, St. Louis, MO
"Etiology of caffeine-withdrawal headache."
- Philip Bain, MD, Clinical Assistant Professor, Medical
College of Wisconsin;
Practicing Internist, Wilkinson Medical Clinic, Hartland,
WI
"Rebound headache: an overview."
- Charles O'Brien, MD, PhD, Professor and Vice Chairman,
Department of Psychiatry,
University of Pennsylvania, Philadelphia, PA.
"Perspectives on habituation and
addiction."
*The opinions expressed in this document are those
of the participants. They do not necessarily reflect
the positions of the sponsor or the National Headache
Foundation.
|